DWYER, Michael, Kamil PARUCH, Marc LABROLI, Carmen ALVAREZ, Kerry KEERTIKAR, Cory POKER, Randall ROSSMAN, Thierry FISCHMANN, Jose DUCA, Vincent MADISON, David PARRY, Nicole DAVIS, Wolfgang SEGHEZZI, Derek WISWELL and Timothy GUZI. Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 1. Bioorganic & Medicinal Chemistry Letters. Elsevier, 2011, vol. 21, No 1, p. 467-470. ISSN 0960-894X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 1.
Name in Czech Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 1.
Authors DWYER, Michael (840 United States of America), Kamil PARUCH (203 Czech Republic, guarantor, belonging to the institution), Marc LABROLI (840 United States of America), Carmen ALVAREZ (840 United States of America), Kerry KEERTIKAR (840 United States of America), Cory POKER (840 United States of America), Randall ROSSMAN (840 United States of America), Thierry FISCHMANN (840 United States of America), Jose DUCA (840 United States of America), Vincent MADISON (840 United States of America), David PARRY (840 United States of America), Nicole DAVIS (840 United States of America), Wolfgang SEGHEZZI (840 United States of America), Derek WISWELL (840 United States of America) and Timothy GUZI (840 United States of America).
Edition Bioorganic & Medicinal Chemistry Letters, Elsevier, 2011, 0960-894X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10401 Organic chemistry
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.554
RIV identification code RIV/00216224:14310/11:00051795
Organization unit Faculty of Science
UT WoS 000285544400096
Keywords in English Kinase CHK1 Pyrazolo[1 5-a]pyrimidine Template
Tags rivok, ZR
Changed by Changed by: Ing. Zdeňka Rašková, učo 140529. Changed: 5/3/2012 11:19.
Abstract
The synthesis and hit-to-lead SAR development of a pyrazolo[1,5-a]pyrimidine hit 4 is described leading to a series of potent, selective CHK1 inhibitors such as compound 17r. In the Letter, the further utility of the pyrazolo[1,5-a]pyrimidine template for the development of potent, selective kinase inhibitors is detailed.
PrintDisplayed: 28/7/2024 01:02